Journal of Biopharmaceutical Statistics

Papers
(The H4-Index of Journal of Biopharmaceutical Statistics is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Heterogeneous logistic regression for estimation of subgroup effects on hypertension19
Estimands, Handling of Missing Data and Impact on Assumed Effect Size and Power in Pivotal COVID-19 Treatment Trials19
Optimised point estimators for multi-stage single-arm phase II oncology trials19
Comparison of profile-likelihood-based confidence intervals with other rank-based methods for the two-sample problem in ordered categorical data17
An adaptive seamless 2-in-1 design with biomarker-driven subgroup enrichment16
A stochastically curtailed single‐arm phase II trial design for binary outcomes13
Different view of the diagnostics test accuracy measures and optimal cut-off point selection procedure under tree or umbrella ordering12
Estimating treatment effect in randomized trial after control to treatment crossover using external controls12
In vitro dissolution profile comparison using bootstrap bias corrected similarity factor, f 210
Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study9
Whole-cage randomization for animal studies with unequal cage or group sizes9
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials9
A practical analysis procedure on generalizing comparative effectiveness in the randomized clinical trial to the real-world trial-eligible population9
Quasi-Empirical Bayes methods for parameter estimation involving many small samples9
0.060258865356445